Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13540* | 2021 |
Activation of a metabolic gene regulatory network downstream of mTOR complex 1 K Düvel, JL Yecies, S Menon, P Raman, AI Lipovsky, AL Souza, ... Molecular cell 39 (2), 171-183, 2010 | 2364 | 2010 |
Bidirectional transport of amino acids regulates mTOR and autophagy P Nicklin, P Bergman, B Zhang, E Triantafellow, H Wang, B Nyfeler, ... Cell 136 (3), 521-534, 2009 | 2050 | 2009 |
Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance JP MacKeigan, LO Murphy, J Blenis Nature cell biology 7 (6), 591-600, 2005 | 736 | 2005 |
A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration LO Murphy, JP MacKeigan, J Blenis Molecular and cellular biology 24 (1), 144-153, 2004 | 444 | 2004 |
Guidelines for the use and interpretation of assays for monitoring autophagy A Diwan, S Hwang, I Mysorekar, WA Weiss | 315* | 2012 |
MEK inhibition enhances paclitaxel-induced tumor apoptosis JP MacKeigan, TS Collins, JPY Ting Journal of Biological Chemistry 275 (50), 38953-38956, 2000 | 285 | 2000 |
Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors BA Ballif, PP Roux, SA Gerber, JP MacKeigan, J Blenis, SP Gygi Proceedings of the National Academy of Sciences 102 (3), 667-672, 2005 | 273 | 2005 |
Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIα JP MacKeigan, CM Clements, JD Lich, RM Pope, Y Hod, JPY Ting Cancer research 63 (20), 6928-6934, 2003 | 229 | 2003 |
Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing MS Stark, SL Woods, MG Gartside, VF Bonazzi, K Dutton-Regester, ... Nature genetics 44 (2), 165-169, 2012 | 226 | 2012 |
The genomic landscape of tuberous sclerosis complex KR Martin, W Zhou, MJ Bowman, J Shih, KS Au, KE Dittenhafer-Reed, ... Nature communications 8 (1), 15816, 2017 | 219 | 2017 |
Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex JP MacKeigan, DA Krueger Neuro-oncology 17 (12), 1550-1559, 2015 | 199 | 2015 |
Mitochondria in cancer: at the crossroads of life and death VC Fogg, NJ Lanning, JP MacKeigan Chinese journal of cancer 30 (8), 526, 2011 | 193 | 2011 |
Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities NJ Lanning, JP Castle, SJ Singh, AN Leon, EA Tovar, A Sanghera, ... Cancer & metabolism 5, 1-14, 2017 | 180 | 2017 |
Biodistribution of radiolabeled lipid–DNA complexes and DNA in mice R Niven, R Pearlman, T Wedeking, J Mackeigan, P Noker, ... Journal of pharmaceutical sciences 87 (11), 1292-1299, 1998 | 160 | 1998 |
A potent and selective ULK1 inhibitor suppresses autophagy and sensitizes cancer cells to nutrient stress KR Martin, SL Celano, AR Solitro, H Gunaydin, M Scott, RC O'Hagan, ... Iscience 8, 74-84, 2018 | 141 | 2018 |
STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinoma BD Looyenga, D Hutchings, I Cherni, C Kingsley, GJ Weiss, ... PloS one 7 (2), e30820, 2012 | 138 | 2012 |
Spatially separate docking sites on ERK2 regulate distinct signaling events in vivo CA Dimitri, W Dowdle, JP MacKeigan, J Blenis, LO Murphy Current Biology 15 (14), 1319-1324, 2005 | 135 | 2005 |
Mitochondrial morphological features are associated with fission and fusion events LM Westrate, JA Drocco, KR Martin, WS Hlavacek, JP MacKeigan PloS one 9 (4), e95265, 2014 | 132 | 2014 |
Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib ML Goodall, T Wang, KR Martin, MG Kortus, AL Kauffman, JM Trent, ... Autophagy 10 (6), 1120-1136, 2014 | 127 | 2014 |